Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.06
AMS's Cash to Debt is ranked lower than
81% of the 241 Companies
in the Global Medical Care industry.

( Industry Median: 0.34 vs. AMS: 0.06 )
Ranked among companies with meaningful Cash to Debt only.
AMS' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 0.27 Max: 1.04
Current: 0.06
0
1.04
Equity to Asset 0.34
AMS's Equity to Asset is ranked lower than
70% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 0.47 vs. AMS: 0.34 )
Ranked among companies with meaningful Equity to Asset only.
AMS' s Equity to Asset Range Over the Past 10 Years
Min: -0.33  Med: 0.32 Max: 0.43
Current: 0.34
-0.33
0.43
Interest Coverage 1.54
AMS's Interest Coverage is ranked lower than
87% of the 201 Companies
in the Global Medical Care industry.

( Industry Median: 7.88 vs. AMS: 1.54 )
Ranked among companies with meaningful Interest Coverage only.
AMS' s Interest Coverage Range Over the Past 10 Years
Min: 0.32  Med: 0.62 Max: 1.79
Current: 1.54
0.32
1.79
F-Score: 6
Z-Score: 0.75
M-Score: -3.09
WACC vs ROIC
9.27%
3.28%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) 11.84
AMS's Operating margin (%) is ranked higher than
65% of the 240 Companies
in the Global Medical Care industry.

( Industry Median: 6.95 vs. AMS: 11.84 )
Ranked among companies with meaningful Operating margin (%) only.
AMS' s Operating margin (%) Range Over the Past 10 Years
Min: -0.32  Med: 6.76 Max: 18.96
Current: 11.84
-0.32
18.96
Net-margin (%) 2.76
AMS's Net-margin (%) is ranked lower than
62% of the 241 Companies
in the Global Medical Care industry.

( Industry Median: 4.75 vs. AMS: 2.76 )
Ranked among companies with meaningful Net-margin (%) only.
AMS' s Net-margin (%) Range Over the Past 10 Years
Min: -9.2  Med: 0.28 Max: 8.12
Current: 2.76
-9.2
8.12
ROE (%) 2.31
AMS's ROE (%) is ranked lower than
77% of the 222 Companies
in the Global Medical Care industry.

( Industry Median: 9.37 vs. AMS: 2.31 )
Ranked among companies with meaningful ROE (%) only.
AMS' s ROE (%) Range Over the Past 10 Years
Min: -7.33  Med: 0.24 Max: 8.87
Current: 2.31
-7.33
8.87
ROA (%) 0.81
AMS's ROA (%) is ranked lower than
74% of the 240 Companies
in the Global Medical Care industry.

( Industry Median: 4.28 vs. AMS: 0.81 )
Ranked among companies with meaningful ROA (%) only.
AMS' s ROA (%) Range Over the Past 10 Years
Min: -2.5  Med: 0.07 Max: 3.33
Current: 0.81
-2.5
3.33
ROC (Joel Greenblatt) (%) 6.03
AMS's ROC (Joel Greenblatt) (%) is ranked lower than
74% of the 240 Companies
in the Global Medical Care industry.

( Industry Median: 19.89 vs. AMS: 6.03 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
AMS' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 1.97  Med: 5.39 Max: 13.22
Current: 6.03
1.97
13.22
Revenue Growth (3Y)(%) -6.70
AMS's Revenue Growth (3Y)(%) is ranked lower than
85% of the 175 Companies
in the Global Medical Care industry.

( Industry Median: 8.20 vs. AMS: -6.70 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
AMS' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -44.3  Med: 1.8 Max: 27.7
Current: -6.7
-44.3
27.7
EBITDA Growth (3Y)(%) -12.80
AMS's EBITDA Growth (3Y)(%) is ranked lower than
86% of the 147 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. AMS: -12.80 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
AMS' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -34.4  Med: 0 Max: 18.5
Current: -12.8
-34.4
18.5
» AMS's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-11-12)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with AMS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care
Compare:OTCPK:CVHIF, AMEX:HH, AMEX:SSY, OTCPK:AMEH, OTCPK:PFHO, OTCPK:BICX, OTCPK:BNKL, OTCPK:SPIN, OTCPK:FDNH, OTCPK:CCEL, OTCPK:QNIIF, OTCPK:FCHS, OTCPK:WNDM, OTCPK:LMNK, NAS:JYNT, OTCPK:USNU, OTCPK:GRST, OTCPK:GNOW, OTCPK:CRNJF, OTCPK:BRRZF » details
Traded in other countries:AZS.Germany,
American Shared Hospital Services provides Gamma Knife stereotactic radiosurgery equipment and radiation therapy and related equipment to seventeen (17) medical centers in sixteen (16) states in the United States and two medical centers in Turkey.

American Shared Hospital Services was incorporated in the State of California in 1983 and its predecessor, Ernest A. Bates, M.D., Ltd. (d/b/a American Shared Hospital Services), a California limited partnership, was formed in June 1980. It provides Gamma Knife stereotactic radiosurgery equipment and radiation therapy and related equipment to seventeen (17) medical centers in sixteen (16) states in the United States and two medical centers in Turkey, as of March 1, 2013. The Gamma Knife stereotactic radiosurgery is a non-invasive procedure and an alternative to conventional brain surgery or can be an adjunct to conventional brain surgery, radiation therapy, or chemotherapy. Compared to conventional surgery, Gamma Knife radiosurgery usually involves shorter patient hospitalization, lower risk of complications and can be provided at a lower cost. Typically, Gamma Knife patients resume their pre-surgical activities one or two days after treatment. The Gamma Knife treats patients with 201 single doses of gamma rays that are focused with great precision on small and medium sized, well circumscribed and critically located structures in the brain. During 2006 Elekta introduced a new Gamma Knife model, the Perfexion unit, which treats patients with 192 single doses of gamma rays and will also provide the ability to perform procedures on areas of the upper cervical spine. The Gamma Knife delivers a concentrated dose of gamma rays from Cobalt-60 sources housed in the Gamma Knife. The Cobalt-60 sources converge at the target area and deliver a dose that is high enough to destroy the diseased tissue without damaging surrounding healthy tissue. The Gamma Knife treats selected malignant and benign brain tumors, arteriovenous malformations, and functional disorders including trigeminal neuralgia (facial pain). Research is being conducted to determine whether the Gamma Knife can be effective in the treatment of epilepsy and other functional disorders. Conventional neurosurgery, radiation therapy and other radiosurgery devices are the primary competitors of Gamma Knife radiosurgery. The Medicare program is administered by the Centers for Medicare and Medicaid Services of the U.S. Department of Health and Human Services.

Ratios

vs
industry
vs
history
P/E(ttm) 34.11
AMS's P/E(ttm) is ranked lower than
61% of the 185 Companies
in the Global Medical Care industry.

( Industry Median: 24.38 vs. AMS: 34.11 )
Ranked among companies with meaningful P/E(ttm) only.
AMS' s P/E(ttm) Range Over the Past 10 Years
Min: 9.11  Med: 23.92 Max: 406.25
Current: 34.11
9.11
406.25
PE(NRI) 34.11
AMS's PE(NRI) is ranked lower than
60% of the 185 Companies
in the Global Medical Care industry.

( Industry Median: 24.69 vs. AMS: 34.11 )
Ranked among companies with meaningful PE(NRI) only.
AMS' s PE(NRI) Range Over the Past 10 Years
Min: 9.11  Med: 23.92 Max: 400
Current: 34.11
9.11
400
Price/Owner Earnings (ttm) 5.81
AMS's Price/Owner Earnings (ttm) is ranked higher than
91% of the 87 Companies
in the Global Medical Care industry.

( Industry Median: 24.55 vs. AMS: 5.81 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
AMS' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 2.09  Med: 6.44 Max: 114.58
Current: 5.81
2.09
114.58
P/B 0.81
AMS's P/B is ranked higher than
95% of the 216 Companies
in the Global Medical Care industry.

( Industry Median: 2.57 vs. AMS: 0.81 )
Ranked among companies with meaningful P/B only.
AMS' s P/B Range Over the Past 10 Years
Min: 0.26  Med: 0.66 Max: 1.99
Current: 0.81
0.26
1.99
P/S 1.01
AMS's P/S is ranked higher than
70% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 1.51 vs. AMS: 1.01 )
Ranked among companies with meaningful P/S only.
AMS' s P/S Range Over the Past 10 Years
Min: 0.24  Med: 0.76 Max: 1.99
Current: 1.01
0.24
1.99
PFCF 2.45
AMS's PFCF is ranked higher than
99% of the 110 Companies
in the Global Medical Care industry.

( Industry Median: 22.02 vs. AMS: 2.45 )
Ranked among companies with meaningful PFCF only.
AMS' s PFCF Range Over the Past 10 Years
Min: 0.87  Med: 2.39 Max: 56
Current: 2.45
0.87
56
POCF 2.10
AMS's POCF is ranked higher than
97% of the 156 Companies
in the Global Medical Care industry.

( Industry Median: 14.24 vs. AMS: 2.10 )
Ranked among companies with meaningful POCF only.
AMS' s POCF Range Over the Past 10 Years
Min: 0.59  Med: 1.76 Max: 4.5
Current: 2.1
0.59
4.5
EV-to-EBIT 15.03
AMS's EV-to-EBIT is ranked higher than
65% of the 184 Companies
in the Global Medical Care industry.

( Industry Median: 19.69 vs. AMS: 15.03 )
Ranked among companies with meaningful EV-to-EBIT only.
AMS' s EV-to-EBIT Range Over the Past 10 Years
Min: 7  Med: 13.7 Max: 75.6
Current: 15.03
7
75.6
EV-to-EBITDA 5.02
AMS's EV-to-EBITDA is ranked higher than
96% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 14.57 vs. AMS: 5.02 )
Ranked among companies with meaningful EV-to-EBITDA only.
AMS' s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.9  Med: 5 Max: 7.2
Current: 5.02
2.9
7.2
Shiller P/E 447.45
AMS's Shiller P/E is ranked lower than
98% of the 47 Companies
in the Global Medical Care industry.

( Industry Median: 27.64 vs. AMS: 447.45 )
Ranked among companies with meaningful Shiller P/E only.
AMS' s Shiller P/E Range Over the Past 10 Years
Min: 2.44  Med: 12.29 Max: 307
Current: 447.45
2.44
307
Current Ratio 0.68
AMS's Current Ratio is ranked lower than
85% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 1.29 vs. AMS: 0.68 )
Ranked among companies with meaningful Current Ratio only.
AMS' s Current Ratio Range Over the Past 10 Years
Min: 0.36  Med: 1.5 Max: 4.13
Current: 0.68
0.36
4.13
Quick Ratio 0.68
AMS's Quick Ratio is ranked lower than
81% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 1.20 vs. AMS: 0.68 )
Ranked among companies with meaningful Quick Ratio only.
AMS' s Quick Ratio Range Over the Past 10 Years
Min: 0.36  Med: 1.5 Max: 4.13
Current: 0.68
0.36
4.13
Days Sales Outstanding 83.46
AMS's Days Sales Outstanding is ranked lower than
87% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 43.53 vs. AMS: 83.46 )
Ranked among companies with meaningful Days Sales Outstanding only.
AMS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 67.01  Med: 79.09 Max: 93.87
Current: 83.46
67.01
93.87
Days Payable 8.03
AMS's Days Payable is ranked lower than
89% of the 149 Companies
in the Global Medical Care industry.

( Industry Median: 38.51 vs. AMS: 8.03 )
Ranked among companies with meaningful Days Payable only.
AMS' s Days Payable Range Over the Past 10 Years
Min: 7.13  Med: 13.46 Max: 27.58
Current: 8.03
7.13
27.58

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -5.20
AMS's 3-Year Average Share Buyback Ratio is ranked lower than
62% of the 124 Companies
in the Global Medical Care industry.

( Industry Median: -2.40 vs. AMS: -5.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
AMS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -10.6  Med: -0.1 Max: 8
Current: -5.2
-10.6
8

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 0.81
AMS's Price/Tangible Book is ranked higher than
96% of the 164 Companies
in the Global Medical Care industry.

( Industry Median: 3.66 vs. AMS: 0.81 )
Ranked among companies with meaningful Price/Tangible Book only.
AMS' s Price/Tangible Book Range Over the Past 10 Years
Min: 0.27  Med: 0.73 Max: 1.83
Current: 0.81
0.27
1.83
Price/Projected FCF 0.32
AMS's Price/Projected FCF is ranked higher than
99% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 1.70 vs. AMS: 0.32 )
Ranked among companies with meaningful Price/Projected FCF only.
AMS' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.15  Med: 0.36 Max: 1
Current: 0.32
0.15
1
Price/Median PS Value 1.33
AMS's Price/Median PS Value is ranked lower than
61% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 1.07 vs. AMS: 1.33 )
Ranked among companies with meaningful Price/Median PS Value only.
AMS' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.15  Med: 1.09 Max: 4.38
Current: 1.33
0.15
4.38
Price/Graham Number 1.10
AMS's Price/Graham Number is ranked higher than
89% of the 111 Companies
in the Global Medical Care industry.

( Industry Median: 2.35 vs. AMS: 1.10 )
Ranked among companies with meaningful Price/Graham Number only.
AMS' s Price/Graham Number Range Over the Past 10 Years
Min: 0.09  Med: 0.95 Max: 3.29
Current: 1.1
0.09
3.29
Earnings Yield (Greenblatt) (%) 6.70
AMS's Earnings Yield (Greenblatt) (%) is ranked higher than
73% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 4.00 vs. AMS: 6.70 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
AMS' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 1.3  Med: 7.3 Max: 14.4
Current: 6.7
1.3
14.4
Forward Rate of Return (Yacktman) (%) 10.05
AMS's Forward Rate of Return (Yacktman) (%) is ranked higher than
62% of the 105 Companies
in the Global Medical Care industry.

( Industry Median: 10.91 vs. AMS: 10.05 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
AMS' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 9.2  Med: 20.7 Max: 53
Current: 10.05
9.2
53

More Statistics

Revenue (TTM) (Mil) $16.79
EPS (TTM) $ 0.09
Beta0.54
Short Percentage of Float0.17%
52-Week Range $1.50 - 3.09
Shares Outstanding (Mil)5.37
» More Articles for AMS

Headlines

Articles On GuruFocus.com
American Shared Hospital Services: Can a Gamma Knife Generate Alpha? Apr 30 2012 
American Shared Hospital Services Reports Operating Results (10-Q) Nov 15 2010 
American Shared Hospital Services (AMS) CHAIRMAN AND CEO, 10% Owner Shared Hospital Services America Sep 14 2010 
American Shared Hospital Services Reports Operating Results (10-Q) Aug 16 2010 
American Shared Hospital Services Reports Operating Results (10-Q) May 17 2010 
American Shared Hospital Services Reports Operating Results (10-Q) Nov 16 2009 
American Shared Hospital Services Reports Operating Results (10-Q) Aug 14 2009 
American Shared Hospital Services Reports Operating Results (10-Q) May 15 2009 

More From Other Websites
American Shared Hospital Services Presents at the MicroCap Leadership Summit Sep 23 2016
Wage talks between South Africa's Amplats, union hit deadlock Sep 20 2016
South Africa's NUM union declares wage dispute with Amplats Sep 20 2016
South Africa's AMCU, platinum mines fail to reach wage deal Sep 05 2016
South Africa's AMCU, platinum mines fail to reach wage deal Sep 05 2016
AMSC and Nexans Expand Relationship to Jointly Develop and Deliver Resilient Electric Grid Projects... Aug 29 2016
AMERICAN SHARED HOSPITAL SERVICES Financials Aug 19 2016
American Shared Hospital Services :AMS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12,... Aug 12 2016
AMERICAN SHARED HOSPITAL SERVICES Files SEC form 10-Q, Quarterly Report Aug 11 2016
AMERICAN SHARED HOSPITAL SERVICES Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 10 2016
American Shared Hospital Services Reports Second Quarter Results Aug 10 2016
American Shared Hospital Services Reports 2016 Second Quarter Results Aug 10 2016
Q2 2016 American Shared Hospital Services Earnings Release - Time Not Supplied Aug 10 2016
AMSC Reports First Quarter Fiscal 2016 Financial Results and Provides Business Outlook Aug 09 2016
American Shared Hospital Services Announces Second Quarter 2016 Results Earnings Conference Call Aug 05 2016
American Shared Hospital Services Announces Second Quarter 2016 Results Earnings Conference Call Aug 05 2016
AMSC to Report First Quarter Financial Results on August 9, 2016 Aug 03 2016
South Africa's Amplats sees H1 earnings down as much as 70 pct on low prices Jul 12 2016
Hobbled by 2014 strike, South Africa platinum producers brace for wage talks Jul 08 2016
South Africa's AMCU union to start wage talks with platinum firms next week Jul 07 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)